JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.
• Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics
• Ten commercial placements of MosaiQ platform in Europe and the US
JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.
JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced changes in the composition of its board of directors that will take effect later this year.
JERSEY, Channel Islands, July 20, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported that an independent study conducted in Madrid, Spain has confirmed the high perform
JERSEY, Channel Islands, July 17, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2020 will be released before market open on Monday, August 3, 2020.
JERSEY, Channel Islands, July 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company has been added to the Russell 2000® and 3000® Indexes
Scientists carrying out coronavirus antibody testing in Scotland are telling Clyde News we still don't have answers on the big question about immunity.
The Honeyman Group, a longstanding Quotient partner, today announced the launch of a new, highly sensitive antibody test utilizing the high-throughput MosaiQ™ platform which coupled with PCR screening can provide a systematic approach for businesses managing teams back-to-work”.
Corona Antikörpertests rücken immer mehr in den Vordergrund. Gross in diesem Geschäft ist der Basler Pharma-Multi Roche. Neu auf dem Markt behauptet sich das Waadtländer Start-up Quotient.